You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Macular%20Degeneration

Showing 26 - 50 of 3,601
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)

Recruiting
  • Neovascular Age-related Macular Degeneration (NVAMD)
  • Diabetic Macular Edema (DME)
  • Phoenix, Arizona
  • +4 more
Jun 14, 2023

Neovascular Age-related Macular Degeneration Trial in Beijing (IBI333)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • IBI333
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Nov 28, 2022

Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)

Completed
  • Age-related Macular Degeneration
  • Blood draw and urine collection
  • Coimbra, Portugal
    AIBILI
Jan 6, 2023

Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (nAMD)
  • EXG102-031
  • (no location specified)
Jun 13, 2023

Age-Related Macular Degeneration Trial in Malvern, Saint Albans (BBC1501)

Not yet recruiting
  • Age-Related Macular Degeneration
  • Malvern, Victoria, Australia
  • +1 more
Apr 5, 2023

Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)

Not yet recruiting
  • Age Related Macular Degeneration (AMD)
  • SPIN
  • Non-aerobic, stretching/balance intervention Control
  • Decatur, Georgia
    Atlanta VA Medical and Rehab Center, Decatur, GA
Jun 26, 2023

Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)

Recruiting
  • Dry Age-related Macular Degeneration
  • Intravitreal injection of CB-PRP
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

Age-Related Macular Degeneration, Geographic Atrophy Trial in Holon (smaller incision, new generation implantable miniature

Not yet recruiting
  • Age-Related Macular Degeneration
  • Geographic Atrophy
  • smaller incision, new generation implantable miniature telescope (SING-IMT)
  • Holon, Tel Aviv, Israel
    Wolfson Medical Center
Jul 3, 2023

Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal

Not yet recruiting
  • Age-Related Macular Degeneration
  • +2 more
  • Non-invasive ultrasound retinal stimulation Device
  • (no location specified)
Jun 19, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Mesa, Phoenix (Faricimab PFS Configuration)

Completed
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Faricimab PFS Configuration
  • Mesa, Arizona
  • +2 more
Jan 2, 2023

Age-Related Macular Degeneration Trial (Active Comparator CT1812, Placebo Comparator)

Not yet recruiting
  • Age-Related Macular Degeneration
  • Active Comparator CT1812
  • Placebo Comparator
  • (no location specified)
Jun 5, 2023

Age-Related Macular Degeneration Trial in Hong Kong (Structured Light Imaging Microscopy)

Recruiting
  • Age-Related Macular Degeneration
  • Structured Light Imaging Microscopy
  • Hong Kong, Guangdong, Hong Kong
    Centre for Eye and Vision Research Limited
Jun 26, 2023

Non-invasive Optical Angiography in Age-related Macular

Recruiting
  • Age Related Macular Degeneration
  • Non-invasive OCT based optical angiography
  • +3 more
  • Vienna, Austria
    Medical University of Vienna
Jan 13, 2023

Artificial Intelligence Diagnostic Aid

Not yet recruiting
  • Wet Macular Degeneration
  • +2 more
  • Macusense Assessment Software
  • London, Westminster, United Kingdom
    Guy's and St Thomas's NHS Foundation Trust
Dec 29, 2022

OKKO Health Hyperacuity, Contrast and Colour Game Validation in

Recruiting
  • Age-Related Macular Degeneration
    • Bristol, United Kingdom
      Bristol
    Nov 16, 2022

    Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration(nAMD)
    • HG202
    • Shanghai, Shanghai, China
    • +1 more
    Sep 4, 2023

    Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)

    Not yet recruiting
    • Geographic Atrophy of the Macula
    • Macular Degeneration
    • Saint Petersburg, Florida
    • +4 more
    Apr 20, 2023

    Geographic Atrophy Trial (BI 771716)

    Not yet recruiting
    • Geographic Atrophy
    • BI 771716
    • (no location specified)
    Aug 29, 2023

    Early Real-world Evidence of Brolucizumab in Neovascular

    Completed
    • Neurovascular Age-related Macular Degeneration
      • Bangalore, India
      • +3 more
      Apr 26, 2023

      Macular Degeneration (AMD) Post-marketing Surveillance in Japan

      Completed
      • Macular Degeneration
      • Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
      • Multiple Locations, Japan
        (unnamed)
      Jan 9, 2023

      Macular Degeneration, Age Related, Cataract Trial (NGenuity)

      Not yet recruiting
      • Macular Degeneration, Age Related
      • Cataract
      • NGenuity
      • (no location specified)
      Aug 3, 2023

      Data of Intravitreal Aflibercept Injection in Patients of Wet

      Completed
      • Wet Age-related Macular Degeneration
      • Aflibercept (Eylea, BAY86-5321)
      • Multiple Locations, India
        Many Locations
      Feb 2, 2023

      Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)

      Recruiting
      • Age-Related Macular Degeneration
      • iPSC-derived RPE/PLGA transplantation
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

      Recruiting
      • Wet Age-related Macular Degeneration
      • Beijing, Beijing, China
        Beijing Hospital
      Feb 3, 2023

      Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

      Not yet recruiting
      • Exudative Age Related Macular Degeneration
      • Winston-Salem, North Carolina
        Wake Forest Health Sciences
      Nov 28, 2022